Dedication, commitment and compassion are the core of Dr. Ninan and his team. Their expertise in providing advanced, minimally-invasive surgical interventions with a personalized approach is unique to thoracic surgery.
Nashville Lung Surgery & Esophageal Center understands a surgical consultation is often anxiety-provoking and believes with an individualized care plan, patients do realize a significant difference.
Bronchoscopic and Minimally Invasive Management of Lung Nodules
Minimally Invasive Lung Cancer Surgery
Management of complex esophageal disorders at Nashville Esophageal Center
GENERAL SURGERY | St. Thomas’ and Harefield Hospital
The Basildon University Hospitals | University of London, U.K.
CARDIOTHORACIC SURGERY | University of Pittsburgh
Medical Center | Pittsburgh, Pennsylvania
THORACIC TRANSPLANTATION | Fellow & Senior Registrar
University of Leeds | Leeds, U.K.
Established the Mid-South Thoracic Multi-Disciplinary Clinic in Memphis, bringing together oncologists, surgeons, pulmonologists in one clinic for thoracic oncology. Quality initiative in lung cancer and thoracic malignancy. Quality initiatives have been implemented in over 450 patients seen in two-year period.
Established the Mid-South Tracheal Clinic in Memphis, a combined unique clinic for complex surgery of tracheal disorders. Performed over 50 complex upper airway tracheo-laryngeal resections with 0 percent mortality.
Established a Minimally Invasive and Robotic Thoracic Surgery Program at Vanderbilt University Medical Center initiating minimally invasive, video-assisted techniques for anatomic and non-anatomic resections of lung cancer, minimally-invasive techniques thoracic sympathectomy, thoracoscopic lung volume reduction surgery and thoracoscopic resection of mediastinal tumors.
Established an Airway and Esophageal Stent Program at Vanderbilt University Medical Center focused on palliative and therapeutic treatment of tumors, stenosis and fistulae.
Served as Primary Lung Transplant Surgeon of Vanderbilt University Medical Center from 2001 to 2007, reaching historic transplant volumes and achieving nationally comparable results with a 98.5 percent 60-day survival rate and an 84 percent one-year survival rate. This multidisciplinary program consisted of physicians from pulmonary medicine and infectious disease.
Established a new inter-department Lung Volume Reduction Surgery Program at Vanderbilt University Medical Center with a 0 percent mortality rate and a 40 percent increase in lung function value. The program brought more than 250 new lung patients needing treatment.
Served as Co-Director of the Lung Cancer SPORE Tissue Core at Vanderbilt University Medical Center’s Ingram Cancer Center